MEDICOX Statistics

Total Valuation

MEDICOX has a market cap or net worth of KRW 19.90 billion. The enterprise value is 28.70 billion.

Market Cap	19.90B
Enterprise Value	28.70B

Important Dates

The next estimated earnings date is Monday, March 24, 2025.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	n/a

Share Statistics

MEDICOX has 58.87 million shares outstanding. The number of shares has increased by 86.28% in one year.

Current Share Class	n/a
Shares Outstanding	58.87M
Shares Change (YoY)	+86.28%
Shares Change (QoQ)	+1.72%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	42.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.57
PB Ratio	0.39
P/TBV Ratio	0.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.04
EV / Sales	0.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.72

Financial Position

The company has a current ratio of 0.71, with a Debt / Equity ratio of 0.39.

Current Ratio	0.71
Quick Ratio	0.52
Debt / Equity	0.39
Debt / EBITDA	n/a
Debt / FCF	-1.86
Interest Coverage	-5.48

Financial Efficiency

Return on equity (ROE) is -48.63% and return on invested capital (ROIC) is -12.88%.

Return on Equity (ROE)	-48.63%
Return on Assets (ROA)	-10.98%
Return on Capital (ROIC)	-12.88%
Revenue Per Employee	369.49M
Profits Per Employee	-339.54M
Employee Count	81
Asset Turnover	0.35
Inventory Turnover	12.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-68.50%
50-Day Moving Average	345.50
200-Day Moving Average	546.62
Relative Strength Index (RSI)	51.04
Average Volume (20 Days)	640,977

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MEDICOX had revenue of KRW 29.93 billion and -27.50 billion in losses. Loss per share was -541.04.

Revenue	29.93B
Gross Profit	1.46B
Operating Income	-15.03B
Pretax Income	-25.64B
Net Income	-27.50B
EBITDA	-12.09B
EBIT	-15.03B
Loss Per Share	-541.04

Full Income Statement

Balance Sheet

The company has 10.90 billion in cash and 19.70 billion in debt, giving a net cash position of -8.80 billion or -149.48 per share.

Cash & Cash Equivalents	10.90B
Total Debt	19.70B
Net Cash	-8.80B
Net Cash Per Share	-149.48
Equity (Book Value)	51.04B
Book Value Per Share	866.98
Working Capital	-6.90B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.19 billion and capital expenditures -370.01 million, giving a free cash flow of -10.56 billion.

Operating Cash Flow	-10.19B
Capital Expenditures	-370.01M
Free Cash Flow	-10.56B
FCF Per Share	-179.42

Full Cash Flow Statement

Margins

Gross margin is 4.87%, with operating and profit margins of -50.22% and -91.89%.

Gross Margin	4.87%
Operating Margin	-50.22%
Pretax Margin	-85.69%
Profit Margin	-91.89%
EBITDA Margin	-40.40%
EBIT Margin	-50.22%
FCF Margin	n/a

Dividends & Yields

MEDICOX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-86.28%
Shareholder Yield	-86.28%
Earnings Yield	-160.07%
FCF Yield	-53.08%

Stock Splits

The last stock split was on November 16, 2022. It was a forward split with a ratio of 2.

Last Split Date	Nov 16, 2022
Split Type	Forward
Split Ratio	2

Scores

MEDICOX has an Altman Z-Score of -1.13. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.13
Piotroski F-Score	n/a